Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4586144
Max Phase: Preclinical
Molecular Formula: C31H32Cl2F3N7O6
Molecular Weight: 612.52
Molecule Type: Unknown
Associated Items:
ID: ALA4586144
Max Phase: Preclinical
Molecular Formula: C31H32Cl2F3N7O6
Molecular Weight: 612.52
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)C/C=C/C(=O)Nc1ccc(C(=O)N2CCC[C@@H](NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)C2)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C29H31Cl2N7O4.C2HF3O2/c1-37(2)14-5-9-24(39)33-19-12-10-18(11-13-19)29(42)38-15-4-6-20(17-38)34-28(41)26-23(16-32-36-26)35-27(40)25-21(30)7-3-8-22(25)31;3-2(4,5)1(6)7/h3,5,7-13,16,20H,4,6,14-15,17H2,1-2H3,(H,32,36)(H,33,39)(H,34,41)(H,35,40);(H,6,7)/b9-5+;/t20-;/m1./s1
Standard InChI Key: PXSBWEUAFKSFKU-ACQWBDGOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 612.52 | Molecular Weight (Monoisotopic): 611.1815 | AlogP: 4.06 | #Rotatable Bonds: 9 |
Polar Surface Area: 139.53 | Molecular Species: BASE | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.75 | CX Basic pKa: 8.80 | CX LogP: 3.97 | CX LogD: 2.64 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.27 | Np Likeness Score: -1.57 |
1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024] |
Source(1):